Search results
Wall Street Analysts See a 133.85% Upside in Evolus, Inc. (EOLS): Can the Stock Really Move This...
Zacks via Yahoo Finance· 4 months agoThe consensus price target hints at a 133.9% upside potential for Evolus, Inc. (EOLS). While...
Has Evolus (EOLS) Outpaced Other Medical Stocks This Year?
Zacks via Yahoo Finance· 2 years agoFor those looking to find strong Medical stocks, it is prudent to search for companies in the group...
Evolus, Inc. (NASDAQ:EOLS) is favoured by institutional owners who hold 57% of the company
Simply Wall St. via Yahoo Finance· 3 weeks agoKey Insights Given the large stake in the stock by institutions, Evolus' stock price might be...
Evolus, Inc. (EOLS) Reports Q3 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 1 year agoEvolus, Inc. (EOLS) delivered earnings and revenue surprises of -18.52% and 8.22%, respectively, for...
Will Evolus, Inc. (EOLS) Report Negative Earnings Next Week? What You Should Know
Zacks via Yahoo Finance· 9 months agoEvolus, Inc. (EOLS) doesn't possess the right combination of the two key ingredients for a likely...
Investors in Evolus (NASDAQ:EOLS) have unfortunately lost 15% over the last three years
Simply Wall St. via Yahoo Finance· 2 years agoIn order to justify the effort of selecting individual stocks, it's worth striving to beat the...
Owning 42% shares,institutional owners seem interested in Evolus, Inc. (NASDAQ:EOLS),
Simply Wall St. via Yahoo Finance· 2 years agoTo get a sense of who is truly in control of Evolus, Inc. (NASDAQ:EOLS), it is important to...
Evolus (NASDAQ:EOLS) rallies 16% this week, taking three-year gains to 161%
Simply Wall St. via Yahoo Finance· 11 months agoIt might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its...
Insiders Pour Millions Into These 2 Stocks, Analysts Say They Have up to 120% Upside — Here’s Why...
TipRanks via Yahoo Finance· 8 months agoLegendary investor Peter Lynch has a straightforward perspective on corporate insiders and their...